An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on an online forum asked whether hypothyroidism (an underactive thyroid) could be why their scale isn’t budging even though they’ve been taking Wegovy for three months. They’re working with their doctor to adjust their thyroid treatment and wanted encouragement or experiences from others. There’s no formal study mentioned — just one person’s report and question. Wegovy is the brand name for a drug called semaglutide. It’s a man-made version of a hormone your gut normally makes after eating that helps signal fullness to your brain and slows how quickly your stomach empties. Doctors prescribe it to help with long-term weight loss when lifestyle changes alone aren’t enough. People often call these drugs “GLP-1 receptor agonists,” which just means they copy that fullness signal so your brain thinks you’ve had more to eat. What we can say about hypothyroidism and semaglutide from this post is limited: it’s an anecdote. The person reports being on Wegovy for three months with no weight loss so far while they’re also having their thyroid dose adjusted. That’s plausible — an underactive thyroid can slow metabolism and make weight loss harder — but the post doesn’t give lab numbers, how strictly calories were controlled, or whether doses and timing of medications are optimized. Larger, controlled studies do show semaglutide helps many people lose weight, but individual responses vary and medical issues like poorly controlled hypothyroidism can blunt results. Why this matters is practical. Lots of people on weight-loss medications also have other health conditions that affect metabolism. If your thyroid isn’t well controlled, you may need different thyroid medication doses before a weight-loss drug works as expected. The takeaway is not to abandon treatment early: three months can be early to judge for some people, and sorting out other medical factors might be needed. If you’re in the same situation, it makes sense to keep communicating with your doctor about thyroid tests, medication timing, and expectations for weight change. Important caveats: this is a single personal post, not scientific evidence. Hypothyroidism has many causes and treatments; changing doses should be done by a clinician with blood tests. Semaglutide can cause side effects like nausea, diarrhea, or constipation, and it’s not safe for everyone (for example, people with certain pancreatitis histories or some rare thyroid cancers may need to avoid it). Insurance coverage and regulatory approvals also affect access. If weight isn’t changing after a few months, ask your doctor to check thyroid levels, review other medications, and consider lifestyle, dosing, and whether continued use of Wegovy is appropriate. Bottom line: If your thyroid isn’t well controlled, it could make semaglutide less effective for weight loss, so work with your clinician and be patient while they sort dosing and expectations.
Source: r/Semaglutide